Researchers review existing data on the molecular basis of senescence and neurodegeneration in age-related brain diseases.
Samsung wins FDA approval for second Soliris biosimilar
Samsung Bioepis said Monday that the FDA approved its biosimilar to AstraZeneca’s blockbuster immunosuppressive drug Soliris. But the approval, for two types of rare blood